Cardiovascular adverse events of tocilizumab and baricitinib in COVID-19 and rheumatoid arthritis: A real-world disproportionality and machine learning analysis.
Overview & Synopsis
Open access biomedical research article published in Medicine (Baltimore).
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Cardiovascular adverse events of tocilizumab and baricitinib in COVID-19 and rheumatoid arthritis: A real-world disproportionality and machine learning analysis. |
|---|---|
| Author / Organization | Moon J, Lee C, Lee S, Kim M, Wen X, Branda F, Oh J, Son Y, Lee K, Choi T, Yon DK |
| Subject & Discipline | Medicine (Baltimore) |
| Categories | Medicine & Health |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-153757 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |